Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19238-43. doi: 10.1073/pnas.1213825109. Epub 2012 Nov 7.
Mutations in the CHD7 gene cause human developmental disorders including CHARGE syndrome. Genetic studies in model organisms have further established CHD7 as a central regulator of vertebrate development. Functional analysis of the CHD7 protein has been hampered by its large size. We used a dual-tag system to purify intact recombinant CHD7 protein and found that it is an ATP-dependent nucleosome remodeling factor. Biochemical analyses indicate that CHD7 has characteristics distinct from SWI/SNF- and ISWI-type remodelers. Further investigations show that CHD7 patient mutations have consequences that range from subtle to complete inactivation of remodeling activity, and that mutations leading to protein truncations upstream of amino acid 1899 of CHD7 are likely to cause a hypomorphic phenotype for remodeling. We propose that nucleosome remodeling is a key function for CHD7 during developmental processes and provide a molecular basis for predicting the impact of disease mutations on that function.
CHD7 基因突变可导致人类发育障碍,包括 CHARGE 综合征。在模式生物中的遗传研究进一步确立了 CHD7 作为脊椎动物发育的中央调节剂。由于 CHD7 蛋白的体积较大,其功能分析受到了阻碍。我们使用双标签系统来纯化完整的重组 CHD7 蛋白,发现它是一种依赖于 ATP 的核小体重塑因子。生化分析表明,CHD7 具有不同于 SWI/SNF-和 ISWI 型重塑因子的特征。进一步的研究表明,CHD7 患者突变的后果从微妙到完全失活重塑活性不等,并且导致 CHD7 上 1899 个氨基酸之前的蛋白质截断的突变很可能导致重塑的低等位基因表型。我们提出核小体重塑是 CHD7 在发育过程中的关键功能,并为预测疾病突变对该功能的影响提供了分子基础。